Scientists launch biobank to study COVID-19 recovery
NCT ID NCT04885504
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is creating a biobank of blood samples and health data from 100 people who have recovered from COVID-19. Researchers will use this information to better understand recovery and long-term effects. No new treatments are being tested; the goal is to provide resources for future studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONAVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental drug aims to tame severe COVID-19 inflammation
- Remote monitoring for COVID-19 in nursing homes: study withdrawn
- Placenta cells tested as COVID fighter – but trial stopped early
- Plasma from COVID-19 survivors tested as treatment for the critically ill
- Healthcare Workers' COVID antibodies under the microscope
- Simple blood test may predict COVID-19 danger in transplant patients